We then profiled the distribution of CD226, CD28, PD-1, and TIGIT expression within NSCLC patient samples (Table S1) by high-dimensional time-of-flight mass cytometry (CyTOF). The gene discussed is CD28; the disease is non-small cell lung carcinoma.